Nasal Decongestant Tablet, Film Coated
NDC Package 50844-112-08
Package Information
Nasal Decongestant (pseudoephedrine hcl) tablets is pseudoephedrine is used for the temporary relief of stuffy nose and sinus pain/pressure caused by infection (such as the common cold, flu) or other breathing illnesses (such as hay fever, allergies, bronchitis). This formulation utilizes a tablet, film coated delivery system. Marketed by L.n.k. International, Inc., this product is identified by NDC 50844-112 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1049160 - pseudoephedrine HCl 30 MG Oral Tablet
- RxCUI: 1049160 - pseudoephedrine hydrochloride 30 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50844 - L.n.k. International, Inc.
- 50844-112 - Nasal Decongestant
- 50844-112-08 - 2 BLISTER PACK in 1 CARTON / 12 TABLET, FILM COATED in 1 BLISTER PACK
- 50844-112 - Nasal Decongestant
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (50844-112). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50844-112-08 identifies a specific commercial package of 2 blister pack in 1 carton / 12 tablet, film coated in 1 blister pack of Nasal Decongestant, a human over the counter drug labeled by L.n.k. International, Inc.. This tablet, film coated is formulated for oral use and contains pseudoephedrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by L.n.k. International, Inc. on August 25, 1981. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Pseudoephedrine is used for the temporary relief of stuffy nose and sinus pain/pressure caused by infection (such as the common cold, flu) or other breathing illnesses (such as hay fever, allergies, bronchitis). Pseudoephedrine is a decongestant (sympathomimetic). It works by narrowing the blood vessels to decrease swelling and congestion. If you are self-treating with this medication, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. (See also Precautions section.) Cough-and-cold products have not been shown to be safe or effective in children younger than 6 years. Long-acting tablets/capsules are not recommended for use in children younger than 12 years. Do not use this pseudoephedrine product in children younger than 12 years unless specifically directed by the doctor. Ask your doctor or pharmacist for more details about using your product safely. These products do not cure or shorten the length of the common cold and may cause serious side effects. To decrease the risk for serious side effects, carefully follow all dosage directions. Do not use this product to make a child sleepy. Do not give other cough-and-cold medication that might contain the same or similar ingredients (see also Drug Interactions section). Ask the doctor or pharmacist about other ways to relieve cough and cold symptoms (such as drinking enough fluids, using a humidifier or saline nose drops/spray).
How is this L.n.k. International, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50844011208. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.